The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Vaginal misoprostol for cervical ripening and induction of labour
Open accessAbstract
BACKGROUND: Misoprostol (Cytotec, Searle) is a prostaglandin E1 analogue widely used for off-label indications such as induction of abortion and of labour. This is one of a series of reviews of methods of cervical ripening and labour induction using standardised methodology. OBJECTIVES: To determine the effects of vaginal misoprostol for third trimester cervical ripening or induction of labour. SEARCH STRATEGY: The Cochrane Pregnancy and Childbirth Group's Trials Register (November 2008) and bibliographies of relevant papers. We updated this search on 30 April 2010 and added the results to the awaiting classification section. SELECTION CRITERIA: Clinical trials comparing vaginal misoprostol used for third trimester cervical ripening or labour induction with placebo/no treatment or other methods listed above it on a predefined list of labour induction methods. DATA COLLECTION AND ANALYSIS: We developed a strategy to deal with the large volume and complexity of trial data relating to labour induction. This involved a two-stage method of data extraction.We used fixed-effect Mantel-Haenszel meta-analysis for combining dichotomous data.If we identified substantial heterogeneity (I² greater than 50%), we used a random-effects method. MAIN RESULTS: We included 121 trials. The risk of bias must be kept in mind as only 13 trials were double blind.Compared to placebo, misoprostol was associated with reduced failure to achieve vaginal delivery within 24 hours (average relative risk (RR) 0.51, 95% confidence interval (CI) 0.37 to 0.71). Uterine hyperstimulation, without fetal heart rate (FHR) changes, was increased (RR 3.52 95% CI 1.78 to 6.99).Compared with vaginal prostaglandin E2, intracervical prostaglandin E2 and oxytocin, vaginal misoprostol was associated with less epidural analgesia use, fewer failures to achieve vaginal delivery within 24 hours and more uterine hyperstimulation. Compared with vaginal or intracervical prostaglandin E2, oxytocin augmentation was less common with misoprostol and meconium-stained liquor more common.Lower doses of misoprostol compared to higher doses were associated with more need for oxytocin augmentation and less uterine hyperstimulation, with and without FHR changes.We found no information on women's views. AUTHORS' CONCLUSIONS: Vaginal misoprostol in doses above 25 mcg four-hourly was more effective than conventional methods of labour induction, but with more uterine hyperstimulation. Lower doses were similar to conventional methods in effectiveness and risks. The authors request information on cases of uterine rupture known to readers. The vaginal route should not be researched further as another Cochrane review has shown that the oral route of administration is preferable to the vaginal route. Professional and governmental bodies should agree guidelines for the use of misoprostol, based on the best available evidence and local circumstances.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Systematic Reviews in Health Care : Meta-Analysis in Context
Egger, M., Smith, G. D., & Altman, D. G. (2000) · Cited by 2,401
Deeks, J. J., Altman, D. G., & Bradburn, M. J. (2001) · Systematic Reviews in Health Care · doi:10.1002/9780470693926.ch15 · Cited by 2,163
Pelvic Scoring for Elective Induction: The Bishop Score
Ajewole, C. S., & Abbott, J. F. (2021) · 50 Studies Every Obstetrician-Gynecologist Should Know · doi:10.1093/med/9780190947088.003.0011 · Cited by 880
PELVIC SCORING FOR ELECTIVE INDUCTION.
Bishop, E. H. (1964) · PubMed · Cited by 852
Chapter 16: Special Topics in Statistics
Higgins, J. P. T., Deeks, J. J., & Altman, D. (2008) · Cited by 728
Absorption kinetics of misoprostol with oral or vaginal administration
ZIEMAN, M., FONG, S., BENOWITZ, N., BANSKTER, D., & DARNEY, P. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00111-7 · Cited by 637
Mechanical methods for induction of labour
Jozwiak, M., Bloemenkamp, K. W., Kelly, A. J., Mol, B. W. J., Irion, O., & Boulvain, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001233.pub2 · Cited by 536
Higgins, J. P., Deeks, J. J., & Altman, D. G. (2008) · Cochrane Handbook for Systematic Reviews of Interventions · doi:10.1002/9780470712184.ch16 · Cited by 475
Cited by
Safe prevention of the primary cesarean delivery
Caughey, A. B., Cahill, A. G., Guise, J.-M., & Rouse, D. J. (2014) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.01.026 · Cited by 1,319
Induction of labour for improving birth outcomes for women at or beyond term
Middleton, P., Shepherd, E., & Crowther, C. A. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004945.pub4 · Cited by 667
Induction of labour for improving birth outcomes for women at or beyond term
Gülmezoglu, A. M., Crowther, C. A., Middleton, P., & Heatley, E. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004945.pub3 · Cited by 411
Self-citationVaginal prostaglandin (PGE2 and PGF2a) for induction of labour at term
Thomas, J., Fairclough, A., Kavanagh, J., & Kelly, A. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003101.pub3 · Cited by 365
Leduc, D., Biringer, A., Lee, L., Dy, J., Corbett, T., Leduc, D., Biringer, A., Duperron, L., Dy, J., Lange, I., et al. (2013) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(15)30842-2 · Cited by 347
Oral misoprostol for induction of labour
Alfirevic, Z., & Weeks, A. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001338.pub2 · Cited by 331
Intravenous oxytocin alone for cervical ripening and induction of labour
Alfirevic, Z., Kelly, A. J., & Dowswell, T. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003246.pub2 · Cited by 255
Metadata
- Authors
- Hofmeyr, G. J., Gülmezoglu, A. M., & Pileggi, C.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- Wiley
- Published
- 2010-10-06
- Volume
- 2013
- Issue
- 1
- Pages
- CD000941-CD000941
- ISSN
- 1361-6137 (ISSN-L)
- 1465-1858
- OpenAlex
- W1932739744
- Cited by
- 510
- References
- 49
- FWCI
- 39.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.